Using the Quantitative Determination of HbsAg to Monitor Antiviral Therapy of Chronic HBV-Infection
Journal Title: Гастроентерологія - Year 2015, Vol 2, Issue 56
Abstract
Currently, the main unresolved issue in monitoring antiviral therapy of chronic HBV-infection is the lack of clear predictors of sustained virologic response to treatment. These predictors would allow early identification of non-responders to the treatment with pegylated interferon and prediction a high probability of preservation of response to the treatment with nucleos(t)id analogs, when the latter is stopped. The way out of this situation can be the use a quantitative assessment of HBsAg, and this review covers this problem.
Authors and Affiliations
I. A. Zaitsev
Keywords
Related Articles
- EP ID EP214674
- DOI -
- Views 73
- Downloads 0
Irritable Bowel Syndrome: Role of Intestinal Microbiota Disorders and Ways of Their Correction
The article presents the correlation between intestinal microbiota disorders and irritable bowel syndrome. The mechanisms of pathogenic role of bowel dysbiosis in the development of irritable bowel syndrome were shown. T...
Clinical and pathogenetic aspects of chronic pancreatitis in combination with viral hepatitis C in outpatient practice
Background. In recent years, attention has increased to an infectious agent whose effects may lead to the development of pancreatic inflammation. Significant prevalence of viral hepatitis C among the population, the vari...
The Role of Sexual Dimorphism in the Development of Non-Alcoholic Fatty Liver Disease
Metabolic liver disease is often accompanies diseases of various body systems. Non-alcoholic fatty liver disease (NAFLD) — the most common pathology, associated with insulin resistance, diabetes mellitus and obesity. Th...
Morphological basis for the assessment of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease associated with obesity and pathology of the biliary tract
Background. The purpose was to study the histopathological features of steatosis, steatohepatitis and liver fibrosis in fatty liver disease of non-alcoholic etiology and to establish the linkages between the degree of st...
Changes in prostaglandin levels in the blood serum of patients with gastroesophageal reflux disease on the background of type 2 diabetes mellitus
Background. Digestive organ damage in patients with diabetes mellitus (DM) is based on several mechanisms: autonomic nervous system dysfunction, angiopathy, dysregulation of secretion and inactivation of hormones and inc...